Searchable abstracts of presentations at key conferences in endocrinology

ea0011p580 | Neuroendocrinology and behaviour | ECE2006

Effect of gastric bypass and gastric banding on neurotensin levels in morbidly obese patients

Christ-Crain M , Stoeckli R , Ernst A , Morgenthaler N , Bilz S , Korbonits M , Bergmann A , Mueller B , Keller U

Objective: Neurotensin is an anorexigenic peptide produced mainly in the N-cells of the ileum; levels are decreased in obese subjects and increase after bariatric surgery. This study is the first to compare the baseline and postoperative levels of neurotensin in patients after gastric bypass, gastric banding, and non-operated controls, respectively, during long-term follow-up.Patients and Methods: Overnight fasting plasma neurotensin levels were measured...

ea0035p18 | Adrenal cortex | ECE2014

Adrenal function in glucocorticoid-treated patients with acute exacerbations of COPD: the ‘REDUCE*' randomized trial

Schuetz Philipp , Leuppi Joerg D , Bingisser Roland , Bodmer Michael , Briel Matthias , Drescher Tillman , Duerring Ursula , Henzen Christoph , Leibbrandt Yolanda , Maier Sabrina , Miedinger David , Muller Beat , Scherr Andreas , Schindler Christian , Stoeckli Rolf , Viatte Sebastien , von Garnier Christophe , Tamm Michael , Rutishauser Jonas

Introduction: Systemic glucocorticoid therapy may put patients at risk for later adrenal failure during times of stress, but tapering increases cumulative steroid exposure. We prospectively evaluated adrenal function and clinically relevant hypocortisolism after abruptly stopping prednisone treatment in patients with exacerbated COPD.Methods: This is a pre-specified analysis of the REDUCE randomized trial (Journal of American Medical Association...